07 Radiol Clin N Am 2007 Ovarian Cancer英文电子书.pdf

149 R A D I O L O G I C C L I N I C S O F N O R T H A M E R I C A Radiol Clin N Am 45 (2007) 149–166 Ovarian Cancer Svetlana Mironov, MD*, Oguz Akin, MD, Neeta Pandit-Taskar, MD, Lucy E. Hann, MD - Epidemiology - Posttreatment follow-up - Relevant histopathology - Recurrent ovarian tumor resectability - Ovarian cancer screening - Summary - Lesion characterization - References - Staging Epidemiology are separated into two major categories: invasive (80%) and noninvasive (borderline) tumors Ovarian cancer is a leading cause of death from gy- (20%), which are associated with different prognos- necologic malignancy and the fifth most common tic characteristics. Epithelial invasive tumors are cause of cancer death in women. It is estimated subdivided further into five histopathologic groups: that in 2006, 20,180 new cases of ovarian cancer serous tumor (50%), mucinous neoplasm (20%), will be diagnosed, and 15,310 women will die of endometrioid carcinoma (20%), clear cell carci- this disease in the United States [1]. Detection of noma (10%), and undifferentiated tumor (5%). stage I disease can